====== Bisphenol F 50μM R08 exp457 ======
==== Mechanism of Action ====
BPA analog and substitute, endocrine disrupter
* **Class / Subclass 1:** Environmental Stresses / Industrial Chemical
==== Technical Notes ====
* **PubChem Name:** %%4,4'-Methylenediphenol%%
* **Synonyms:** N/A
* **CAS #:** 620-92-8
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/12111|12111]]
* **IUPAC:** %%4-[(4-hydroxyphenyl)methyl]phenol%%
* **INCHI Name:** InChI=1S/C13H12O2/c14-12-5-1-10(2-6-12)9-11-3-7-13(15)8-4-11/h1-8,14-15H,9H2
* **INCHI Key:** PXKLMJQFEQBVLD-UHFFFAOYSA-N
* **Molecular Weight:** 200.23
* **Canonical SMILES:** C1=CC(=CC=C1CC2=CC=C(C=C2)O)O
* **Isomeric SMILES:** N/A
* **Molecular Formula:** C13H12O2
{{:chemogenomics:structures:chem-0267.svg?nolink}}
* **Supplier Name:** Ark Pharm Inc.
* **Catalog #:** AK122333
* **Lot #:** WG0092170-160531001
* **HRMS (ESI-TOF) m/z:** (M-H)- Calcd for C13 H12 O2 199.07645; found 199.07755
* **Platform ID:** Bisphenol_F
* **Min:** -11.8847; **Max:** 7.7151
{{:chemogenomics:dose_response:dr_418.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |N/A |
| IC30 |N/A |
| IC40 |N/A |
| IC50 |N/A |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 08
* **Dose**: 50µM
* **Days of incubation**: 8
* **Doublings**: 5.5
* **Numbers of reads**: 14290606
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|4/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Bisphenol_F_50uM_Round-8_exp457.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp457.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:A:ALG9|ALG9]]|-3.72|<0.01|
|[[:human_genes:T:TMEM189|TMEM189]]|-2.97|<0.01|
|[[:human_genes:S:SCD|SCD]]|-2.93|0.03|
|[[:human_genes:V:VPS25|VPS25]]|-2.84|0.27|
|[[:human_genes:O:ORC3|ORC3]]|-2.64|0.04|
|[[:human_genes:T:TPRKB|TPRKB]]|-2.56|0.09|
|[[:human_genes:A:ACSL4|ACSL4]]|-2.52|0.10|
|[[:human_genes:K:KDSR|KDSR]]|-2.51|0.07|
|[[:human_genes:C:CAPRIN2|CAPRIN2]]|-2.46|0.07|
|[[:human_genes:Z:ZNF708|ZNF708]]|-2.46|0.15|
|[[:human_genes:T:TSSC1|TSSC1]]|-2.36|0.10|
|[[:human_genes:A:ADIPOR2|ADIPOR2]]|-2.33|0.10|
|[[:human_genes:A:ARL1|ARL1]]|-2.31|0.10|
|[[:human_genes:S:SCYL1|SCYL1]]|-2.30|0.15|
|[[:human_genes:N:NPRL3|NPRL3]]|-2.30|0.22|
|[[:human_genes:C:CEPT1|CEPT1]]|-2.29|0.11|
|[[:human_genes:F:FAF2|FAF2]]|-2.27|0.23|
|[[:human_genes:V:VPS52|VPS52]]|-2.22|0.51|
|[[:human_genes:S:SCNN1A|SCNN1A]]|-2.22|0.14|
|[[:human_genes:A:ALG12|ALG12]]|-2.20|0.14|
|[[:human_genes:T:TMEM189-UBE2V1|TMEM189-UBE2V1]]|-2.19|0.14|
|[[:human_genes:S:SURF4|SURF4]]|-2.19|0.14|
|[[:human_genes:C:COG5|COG5]]|-2.17|0.22|
|[[:human_genes:T:TMEM131|TMEM131]]|-2.16|0.22|
|[[:human_genes:D:DNAJC3|DNAJC3]]|-2.15|0.15|
|[[:human_genes:T:TRPM8|TRPM8]]|-2.11|0.23|
|[[:human_genes:C:C2orf53|C2orf53]]|-2.11|0.18|
|[[:human_genes:D:DPAGT1|DPAGT1]]|-2.10|0.23|
|[[:human_genes:C:CDIPT|CDIPT]]|-2.09|0.49|
|[[:human_genes:R:RAD9A|RAD9A]]|-2.09|0.59|
|[[:human_genes:N:NFYB|NFYB]]|1.87|0.80|
|[[:human_genes:N:NIPBL|NIPBL]]|1.88|0.80|
|[[:human_genes:B:BRD8|BRD8]]|1.90|0.80|
|[[:human_genes:P:PSMD8|PSMD8]]|1.90|0.80|
|[[:human_genes:F:FZD1|FZD1]]|1.90|0.80|
|[[:human_genes:P:PI4KB|PI4KB]]|1.91|0.80|
|[[:human_genes:N:NRAP|NRAP]]|1.91|0.80|
|[[:human_genes:A:ANKRD24|ANKRD24]]|1.92|0.80|
|[[:human_genes:C:CDKN1C|CDKN1C]]|1.92|0.80|
|[[:human_genes:D:DENR|DENR]]|1.94|0.80|
|[[:human_genes:P:PRPF19|PRPF19]]|1.94|0.80|
|[[:human_genes:M:MGAT4D|MGAT4D]]|1.95|0.82|
|[[:human_genes:I:IQCC|IQCC]]|1.96|0.80|
|[[:human_genes:A:ANKRD40|ANKRD40]]|1.96|0.80|
|[[:human_genes:S:SHMT2|SHMT2]]|1.97|0.80|
|[[:human_genes:P:PSPC1|PSPC1]]|1.97|0.80|
|[[:human_genes:C:CYBA|CYBA]]|2.03|0.80|
|[[:human_genes:T:TPX2|TPX2]]|2.03|0.80|
|[[:human_genes:O:OR4M2|OR4M2]]|2.03|0.80|
|[[:human_genes:M:MAU2|MAU2]]|2.06|0.80|
|[[:human_genes:G:GAGE2A|GAGE2A]]|2.10|0.80|
|[[:human_genes:R:RERG|RERG]]|2.12|0.80|
|[[:human_genes:D:DDR2|DDR2]]|2.13|0.80|
|[[:human_genes:X:XPO1|XPO1]]|2.17|0.80|
|[[:human_genes:H:HSPA12B|HSPA12B]]|2.18|0.80|
|[[:human_genes:H:HIST1H2BL|HIST1H2BL]]|2.20|0.80|
|[[:human_genes:I:IK|IK]]|2.24|0.80|
|[[:human_genes:R:RPS4X|RPS4X]]|2.28|0.80|
|[[:human_genes:N:NATD1|NATD1]]|2.29|0.80|
|[[:human_genes:P:POLE2|POLE2]]|2.42|0.80|
^Screen^Correlation^Plot^
|[[:results:exp326|CCT251545 20μM R07 exp326]]|0.101||
|[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|0.085||
|[[:results:exp149|SB203580 25μM R03 exp149]]|0.078||
|[[:results:exp422|Wiskostatin 3μM R07 exp422]]|0.078||
|[[:results:exp83|Trametinib 10μM R02 exp83]]|0.078||
|[[:results:exp483|FTY720 3μM R08 exp483]]|0.076||
|[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|0.071||
|[[:results:exp538|ZLN024 50μM R08 exp538]]|0.069||
|[[:results:exp530|Thioridazine 5μM R08 exp530]]|0.068||
|[[:results:exp379|MSC2530818 10μM R07 exp379]]|0.066||
|[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|0.064||
|[[:results:exp293|Myriocin 25μM R06 exp293]]|0.061||
|[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|0.06||
|[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|0.059||
|[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|0.059||
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|0.053||
|[[:results:exp47|Lapatinib 5μM R01 exp47]]|0.051||
|[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|0.051||
|[[:results:exp453|B02 10μM R08 exp453]]|0.066||
|[[:results:exp269|Bisphenol A 100μM R06 exp269]]|0.061||
|[[:results:exp461|BS-181 20μM R08 exp461]]|0.059||
{{:chemogenomics:comparison_plots:exp326_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp77.png?nolink |}}
{{:chemogenomics:comparison_plots:exp149_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp422_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp83.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp483.png?nolink |}}
{{:chemogenomics:comparison_plots:exp344_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp538.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp530.png?nolink |}}
{{:chemogenomics:comparison_plots:exp379_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp508.png?nolink |}}
{{:chemogenomics:comparison_plots:exp293_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp537.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp490.png?nolink |}}
{{:chemogenomics:comparison_plots:exp101_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp47.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp506.png?nolink |}}
{{:chemogenomics:comparison_plots:exp453_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp269_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp457_vs_exp461.png?nolink |}}
^GO Term^Fold Change^Genes^
|dolichol-linked oligosaccharide biosynthetic process|109.01|ALG9,ALG12,DPAGT1|
|oligosaccharide-lipid intermediate biosynthetic process|103.56|ALG9,ALG12,DPAGT1|
|phosphotransferase activity, for other substituted phosphate groups|98.62|CEPT1,DPAGT1,CDIPT|
|dolichol metabolic process|98.62|ALG9,ALG12,DPAGT1|
|polyprenol metabolic process|90.05|ALG9,ALG12,DPAGT1|
|endosomal transport|14.88|VPS25,EIPR1,ARL1,VPS52,SURF4|
|cellular lipid metabolic process|7.04|ALG9,SCD,ACSL4,KDSR,ADIPOR2,CEPT1,ALG12,DPAGT1,CDIPT|
No GO term hits below threshold. (FDR <0.05)